Sanofi SA SAN-FR:Euronext Paris

*Data is delayed | EUR
Last | 03/05/21 CET
77.38quote price arrow up+0.63 (+0.82%)
Volume
2,729,623
52 week range
67.65 - 95.82

...

Loading . . .

KEY STATS

  • Open76.76
  • Day High77.68
  • Day Low76.35
  • Prev Close76.75
  • 52 Week High95.82
  • 52 Week High Date07/21/20
  • 52 Week Low67.65
  • 52 Week Low Date03/16/20
  • Market Cap115,625.07M
  • Shares Out1,250.69M
  • 10 Day Average Volume2.21M
  • Dividend3.20
  • Dividend Yield4.14%
  • Beta0.42
  • 1 Year % Change-13.51

RATIOS/PROFITABILITY

  • EPS (TTM)9.83
  • P/E (TTM)7.87
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/04/2020
  • Div Amount3.15
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment...
Serge Weinberg
Chairman
Paul Hudson
Chief Executive Officer
Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer
Karen Linehan
Executive Vice President
John Reed M.D., Ph.D.
Executive Vice President
Address
54 rue la Boetie
Paris
75008
France